UK Cancer Vaccines Market Size & Outlook, 2026-2033

The cancer vaccines market in UK is expected to reach a projected revenue of US$ 1,094.7 million by 2033. A compound annual growth rate of 12.7% is expected of UK cancer vaccines market from 2026 to 2033.
Revenue, 2025 (US$M)
$420.8
Forecast, 2033 (US$M)
$1,094.7
CAGR, 2026 - 2033
12.7%
Report Coverage
UK

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UK cancer vaccines market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UK cancer vaccines market highlights

  • The UK cancer vaccines market generated a revenue of USD 420.8 million in 2025 and is expected to reach USD 1,094.7 million by 2033.
  • The UK market is expected to grow at a CAGR of 12.7% from 2026 to 2033.
  • In terms of segment, recombinant cancer vaccines was the largest revenue generating technology type in 2025.
  • Viral Vector and DNA Cancer Vaccines is the most lucrative technology type segment registering the fastest growth during the forecast period.


Cancer vaccines market data book summary

Market revenue in 2025USD 420.8 million
Market revenue in 2033USD 1,094.7 million
Growth rate12.7% (CAGR from 2026 to 2033)
Largest segmentRecombinant cancer vaccines
Fastest growing segmentViral Vector and DNA Cancer Vaccines
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationViral Vector and DNA Cancer Vaccines, Other Technologies, Recombinant Cancer Vaccines, Whole-cell Cancer Vaccines
Key market players worldwideMerck & Co Inc, GSK PLC, Dynavax Technologies, Ferring, Amgen Inc, Moderna Inc, Sanofi SA, AstraZeneca PLC, Bristol-Myers Squibb Co


Other key industry trends

  • In terms of revenue, UK accounted for 4.2% of the global cancer vaccines market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany cancer vaccines market is projected to lead the regional market in terms of revenue in 2033.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 1,644.1 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cancer Vaccines Market Companies

Name Profile # Employees HQ Website
Dynavax Technologies View profile 501-1000 Berkeley, California, United States, North America http://www.dynavax.com
Moderna Inc View profile 5600 200 Technology Square, Cambridge, MA, United States, 02139 https://www.modernatx.com
Ferring View profile 5001-10000 Saint-prex, Vaud, Switzerland, Europe https://www.ferring.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
GSK PLC View profile 70200 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS https://www.gsk.com
Bristol-Myers Squibb Co View profile 34100 Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 https://www.bms.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Amgen Inc View profile 26700 One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 https://www.amgen.com

UK cancer vaccines market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cancer vaccines market will help companies and investors design strategic landscapes.


Recombinant cancer vaccines was the largest segment with a revenue share of 63.24% in 2025. Horizon Databook has segmented the UK cancer vaccines market based on viral vector and dna cancer vaccines, other technologies, recombinant cancer vaccines, whole-cell cancer vaccines covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to UK cancer vaccines market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UK cancer vaccines market databook

  • Our clientele includes a mix of cancer vaccines market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UK cancer vaccines market , including forecasts for subscribers. This country databook contains high-level insights into UK cancer vaccines market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UK cancer vaccines market size, by vaccine type, 2021-2033 (US$M)

UK Cancer Vaccines Market Outlook Share, 2025 & 2033 (US$M)

UK cancer vaccines market size, by vaccine type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online